The supplementation with L. reuteri V3401 (5 × 109 CFU for three months) in patients with metabolic syndrome resulted in IL-6 and soluble vascular cell adhesion molecule 1 (sVCAM-1) decrease associated with a rise in the proportion of Verrucomicrobia (195). Here, IL6 is linked to metabolic syndrome.